Indena further expands its custom development and manufacturing capacity
for HPAPIs. From small scale GLP batches for toxicology and cGMP batches for clinical trials to large-scale commercial manufacturing, the company can now handle synthetic and natural compounds with an OEL of 20 ng/m3.